Hill, William W; Lim, Emilia L EL; Weeden, Clare E CE; Lee, Claudia C; Augustine, Marcellus M; Chen, Kezhong K; Kuan, Feng-Che FC; Marongiu, Fabio F; Evans, Edward J EJ; Moore, David A DA; Rodrigues, Felipe S FS; Pich, Oriol O; Bakker, Bjorn B; Cha, Hongui H; Myers, Renelle R; van Maldegem, Febe F; Boumelha, Jesse J; Veeriah, Selvaraju S; Rowan, Andrew A; Naceur-Lombardelli, Cristina C; Karasaki, Takahiro T; Sivakumar, Monica M; De, Swapnanil S; Caswell, Deborah R DR; Nagano, Ai A; Black, James R M JRM; Martínez-Ruiz, Carlos C; Ryu, Min Hyung MH; Huff, Ryan D RD; Li, Shijia S; Favé, Marie-Julie MJ; Magness, Alastair A; Suárez-Bonnet, Alejandro A; Priestnall, Simon L SL; Lüchtenborg, Margreet M; Lavelle, Katrina K; Pethick, Joanna J; Hardy, Steven S; McRonald, Fiona E FE; Lin, Meng-Hung MH; Troccoli, Clara I CI; Ghosh, Moumita M; Miller, York E YE; Merrick, Daniel T DT; Keith, Robert L RL; Al Bakir, Maise M; Bailey, Chris C; Hill, Mark S MS; Saal, Lao H LH; Chen, Yilun Y; George, Anthony M AM; Abbosh, Christopher C; Kanu, Nnennaya N; Lee, Se-Hoon SH; McGranahan, Nicholas N; Berg, Christine D CD; Sasieni, Peter P; Houlston, Richard R; Turnbull, Clare C; Lam, Stephen S; Awadalla, Philip P; Grönroos, Eva E; Downward, Julian J; Jacks, Tyler T; Carlsten, Christopher C; Malanchi, Ilaria I; Hackshaw, Allan A; Litchfield, Kevin K; , ; DeGregori, James J; Jamal-Hanjani, Mariam M; Swanton, Charles C
Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study.
Jto Clinical And Research Reports
Ji, Jingran J; Aredo, Jacqueline V JV; Piper-Vallillo, Andrew A; Huppert, Laura L; Rotow, Julia K JK; Husain, Hatim H; Stewart, Susan S; Cobb, Rosemary R; Wakelee, Heather A HA; Blakely, Collin M CM; Wong, Melisa L ML; Gubens, Matthew A MA; Madani, Mohammad H MH; Digumarthy, Subba R SR; McCoach, Caroline C; Piotrowska, Zofia Z; Neal, Joel W JW; Riess, Jonathan W JW
Dacomitinib for Advanced Non-small Cell Lung Cancer Patients Harboring Major Uncommon EGFR Alterations: A Dual-Center, Single-Arm, Ambispective Cohort Study in China.
Frontiers In Pharmacology
Li, Hong-Shuai HS; Yang, Guang-Jian GJ; Cai, Yi Y; Li, Jun-Ling JL; Xu, Hai-Yan HY; Zhang, Tao T; Zhou, Li-Qiang LQ; Wang, Yu-Ying YY; Wang, Jin-Liang JL; Hu, Xing-Sheng XS; Yan, Xiang X; Wang, Yan Y
Unique characteristics of G719X and S768I compound double mutations of epidermal growth factor receptor (EGFR) gene in lung cancer of coal-producing areas of East Yunnan in Southwestern China.
Genes And Environment : The Official Journal Of The Japanese Environmental Mutagen Society
Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT).
Therapeutic Advances In Medical Oncology
Addeo, Alfredo A; Hochmair, Maximilian M; Janzic, Urska U; Dudnik, Elizabeth E; Charpidou, Andriani A; Płużański, Adam A; Ciuleanu, Tudor T; Donev, Ivan Shterev IS; Elbaz, Judith J; Aarøe, Jørgen J; Ott, René R; Peled, Nir N
Phase 1b Open-Label Trial of Afatinib Plus Xentuzumab (BI 836845) in Patients With EGFR Mutation-Positive NSCLC After Progression on EGFR Tyrosine Kinase Inhibitors.
Jto Clinical And Research Reports
Park, Keunchil K; Tan, Daniel Shao Weng DSW; Su, Wu-Chou WC; Cho, Byoung Chul BC; Kim, Sang-We SW; Lee, Ki Hyeong KH; Wang, Chin-Chou CC; Seto, Takashi T; Huang, Dennis Chin-Lun DC; Jung, Helen Hayoun HH; Hsu, Ming-Chi MC; Bogenrieder, Thomas T; Lin, Chia-Chi CC
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung Cancer.
Cancer Discovery
Jänne, Pasi A PA; Baik, Christina C; Su, Wu-Chou WC; Johnson, Melissa L ML; Hayashi, Hidetoshi H; Nishio, Makoto M; Kim, Dong-Wan DW; Koczywas, Marianna M; Gold, Kathryn A KA; Steuer, Conor E CE; Murakami, Haruyasu H; Yang, James Chih-Hsin JC; Kim, Sang-We SW; Vigliotti, Michele M; Shi, Rong R; Qi, Zhenhao Z; Qiu, Yang Y; Zhao, Lihui L; Sternberg, David D; Yu, Channing C; Yu, Helena A HA
A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses.
Cancers
Koopman, Bart B; Cajiao Garcia, Betzabel N BN; Kuijpers, Chantal C H J CCHJ; Damhuis, Ronald A M RAM; van der Wekken, Anthonie J AJ; Groen, Harry J M HJM; Schuuring, Ed E; Willems, Stefan M SM; van Kempen, Léon C LC
Development of EGFR TKIs and Options to Manage Resistance of Third-Generation EGFR TKI Osimertinib: Conventional Ways and Immune Checkpoint Inhibitors.
Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
The Cochrane Database Of Systematic Reviews
Ferrara, Roberto R; Imbimbo, Martina M; Malouf, Reem R; Paget-Bailly, Sophie S; Calais, François F; Marchal, Corynne C; Westeel, Virginie V
Clinical significance of anemia as a prognostic factor in non-small cell lung cancer carcinoma with activating epidermal growth factor receptor mutations.
Journal Of Thoracic Disease
Kang, Hye Seon HS; Shin, Ah Young AY; Yeo, Chang Dong CD; Park, Chan Kwon CK; Kim, Ju Sang JS; Kim, Jin Woo JW; Kim, Seung Joon SJ; Lee, Sang Haak SH; Kim, Sung Kyoung SK
Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC).
Lung Cancer (Amsterdam, Netherlands)
Gelatti, Ana C Z ACZ; Drilon, Alexander A; Santini, Fernando C FC
Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations.
The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma.
Plos One
de Biase, Dario D; Genestreti, Giovenzio G; Visani, Michela M; Acquaviva, Giorgia G; Di Battista, Monica M; Cavallo, Giovanna G; Paccapelo, Alexandro A; Cancellieri, Alessandra A; Trisolini, Rocco R; Degli Esposti, Roberta R; Bartolini, Stefania S; Pession, Annalisa A; Tallini, Giovanni G; Brandes, Alba A AA